| Literature DB >> 23484777 |
Dilek Uludağ1, Nihal Ozdemir, Gülen Tüysüz, Ayşe Güler Eroğlu, Tiraje Celkan.
Abstract
Voriconazole is a triazole antifungal drug that is used to treat invasive fungal infections, especially aspergillus. Here, we report two children who had severe bradycardia associated with voriconazole at a dose of 12 mg/kg per day. Bradycardia resolved in 24 hours in both after decreasing the dose to 10 mg/kg per day. Heart rates were in normal limits on follow-up. Bradycardia may be a side effect of voriconazole treatment in children under immunosuppressive treatment. Heart rate should be monitored in patients receiving voriconazole and other triazole treatments.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23484777 DOI: 10.3109/08880018.2013.775616
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN: 0888-0018 Impact factor: 1.969